|
Report No. : |
328143 |
|
Report Date : |
22.06.2015 |
IDENTIFICATION DETAILS
|
Name : |
Z-MEDICA, LLC |
|
|
|
|
Registered Office : |
4 Fairfield Blvd, Wallingford, CT 06492 |
|
|
|
|
Country : |
United States |
|
|
|
|
Date of Incorporation : |
27.08.2012 |
|
|
|
|
Legal Form : |
LLC |
|
|
|
|
Line of Business : |
Manufactures and Distributes of Haemostasis Agents. |
|
|
|
|
No. of Employees : |
68 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Slow but correct |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
United States |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
UNITED STATES - ECONOMIC
OVERVIEW
The US has the most technologically powerful economy in the world, with a per capita GDP of $54,800. In 2014, however, US GDP ran second to China’s, when compared on a Purchasing Power Parity basis; the US lost the top spot, where it had stood for more than a century. In the US, private individuals and business firms make most of the decisions, and the federal and state governments buy needed goods and services predominantly in the private marketplace. US business firms enjoy greater flexibility than their counterparts in Western Europe and Japan in decisions to expand capital plant, to lay off surplus workers, and to develop new products. At the same time, they face higher barriers to enter their rivals' home markets than foreign firms face entering US markets. US firms are at or near the forefront in technological advances, especially in computers and in medical, aerospace, and military equipment; their advantage has narrowed since the end of World War II. The onrush of technology has been a driving factor in the gradual development of a "two-tier labor market" in which those at the bottom lack the education and the professional/technical skills of those at the top and, more and more, fail to get comparable pay raises, health insurance coverage, and other benefits. But the globalization of trade, and especially the rise of low-wage producers, has put additional downward pressure on wages and upward pressure on the returns to capital. Since 1975, practically all the gains in household income have gone to the top 20% of households. Since 1996, dividends and capital gains have grown faster than wages or any other category of after-tax income. Imported oil accounts for nearly 55% of US consumption. Crude oil prices doubled between 2001 and 2006, the year home prices peaked; higher gasoline prices ate into consumers' budgets and many individuals fell behind in their mortgage payments. Oil prices climbed another 50% between 2006 and 2008, and bank foreclosures more than doubled in the same period. Besides dampening the housing market, soaring oil prices caused a drop in the value of the dollar and a deterioration in the US merchandise trade deficit, which peaked at $840 billion in 2008. The sub-prime mortgage crisis, falling home prices, investment bank failures, tight credit, and the global economic downturn pushed the United States into a recession by mid-2008. GDP contracted until the third quarter of 2009, making this the deepest and longest downturn since the Great Depression.
To help stabilize financial markets, in October 2008 the US Congress established a $700 billion Troubled Asset Relief Program (TARP). The government used some of these funds to purchase equity in US banks and industrial corporations, much of which had been returned to the government by early 2011. In January 2009 the US Congress passed and President Barack OBAMA signed a bill providing an additional $787 billion fiscal stimulus to be used over 10 years - two-thirds on additional spending and one-third on tax cuts - to create jobs and to help the economy recover. In 2010 and 2011, the federal budget deficit reached nearly 9% of GDP. In 2012, the federal government reduced the growth of spending and the deficit shrank to 7.6% of GDP. Wars in Iraq and Afghanistan required major shifts in national resources from civilian to military purposes and contributed to the growth of the budget deficit and public debt. Through 2014, the direct costs of the wars totaled more than $1.5 trillion, according to US Government figures. US revenues from taxes and other sources are lower, as a percentage of GDP, than those of most other countries. In March 2010, President OBAMA signed into law the Patient Protection and Affordable Care Act, a health insurance reform that was designed to extend coverage to an additional 32 million American citizens by 2016, through private health insurance for the general population and Medicaid for the impoverished. Total spending on health care - public plus private - rose from 9.0% of GDP in 1980 to 17.9% in 2010. In July 2010, the president signed the DODD-FRANK Wall Street Reform and Consumer Protection Act, a law designed to promote financial stability by protecting consumers from financial abuses, ending taxpayer bailouts of financial firms, dealing with troubled banks that are "too big to fail," and improving accountability and transparency in the financial system - in particular, by requiring certain financial derivatives to be traded in markets that are subject to government regulation and oversight. In December 2012, the Federal Reserve Board (Fed) announced plans to purchase $85 billion per month of mortgage-backed and Treasury securities in an effort to hold down long-term interest rates, and to keep short term rates near zero until unemployment dropped below 6.5% or inflation rose above 2.5%. In late 2013, the Fed announced that it would begin scaling back long-term bond purchases to $75 billion per month in January 2014 and reduce them further as conditions warranted; the Fed ended the purchases during the summer of 2014. Long-term problems include stagnation of wages for lower-income families, inadequate investment in deteriorating infrastructure, rapidly rising medical and pension costs of an aging population, energy shortages, and sizable current account and budget deficits.
|
Source
: CIA |
Company name: Z-MEDICA, LLC
Address: 4 Fairfield Blvd,
Wallingford, CT 06492 - USA
Telephone: +1
203-294-0000
Fax: +1 800-343-8656
Website: www.quicklot.com
Corporate ID#: 5204415
State: Delaware
Judicial form: LLC
Date incorporated: 08-27-2012
Stock: -
Value: -
Name of manager: Stephen
F. FANNING
Business:
Z-MEDICA LLC manufactures and distributes haemostasis agents.
It offers sterile nonwoven gauzes, haemostatic bandages, hydrophilic
roll dressings, and haemostatic sponges impregnated with kaolin.
The company also offers specialty haemostasis products for use in the
fields of podiatry, emergency medicine, cardiology, critical care, orthopedics,
obstetrics/gynecology, and dermatology.
It serves military, first responders, healthcare professionals, law enforcement
and emergency response markets, and veterinary markets.
Office
of the Foreign Assets Control (OFAC):
The company is not listed on the OFAC list.
The Specially Designated Nationals (SDN) List is a publication of OFAC which
lists individuals and organizations with whom United States citizens and
permanent residents are prohibited from doing business.
No name of foreign suppliers available.
EIN: -
Staff: 68
Operations & branches:
At the headquarters, we
find a laboratory and office.
Shareholders:
Z-MEDICAL HOLDINGS, LLC
4 Fairfield Blvd,
Wallingford, CT 06492
Management:
Stephen J. FANNING has been President and CEO since April 2014.
Mr. Fanning served as the Chief Executive Officer and President of Solta
Medical, Inc. (alternate name is Thermage Inc.) from January 15, 2005 to 2013.
Mr. Fanning served as the Vice President of Global Sales of Solta Medical, Inc.
since January 27, 2013. He has over 30 years of senior leadership experience in
the consumer pharmaceutical and medical device industries.
Mr. Fanning served as Chief Executive Officer and President of Ocular
Sciences Inc. from August 2001 to 2005. Mr. Fanning joined Ocular Sciences Inc.
from Johnson & Johnson, where he served in various senior executive
positions for 25 years, including as President of Worldwide of Johnson &
Johnson's McNeil Specialty Products division, where he was responsible for all
business functions including sales, marketing, research and development and
operations. He served as President of Johnson & Johnson Medical, a medical
device company. Mr. Fanning has also served as Managing Director of Johnson
& Johnson Austria/Switzerland, and Vice President of Sales of Johnson &
Johnson's McNeil Consumer Products Division. Mr. Fanning served at Johnson
& Johnson until 2001. Mr. Fanning served as Executive Chairman of Solta
Medical, Inc. from July 2006 to June 12, 2013 and also served as its Executive
Director until June 12, 2013. He has been a Director of Syneron Medical Ltd.
since February 18, 2014. He serves as a member of the board of directors of
SynergEyes, and Johns Hopkins University School of Nursing Advisory Council.
Mr. Fanning served as a Director of Fibrocell Science, Inc. (formerly
Isolagen, Inc.) since June 23, 2005 and Ocular Sciences Inc. since August 2001
until it was acquired by CooperVision.
Mr. Fanning holds a Bachelor of Science degree from Philadelphia
University.
Douglas SCHILLINGER is the Chairman.
David M. DEAN is COO and CFO.
As far as we know, they are involved in other corporations, including:
Z-MEDICA CORPORATION, INC.
Z-MEDICA HOLDINGS, LLC
In United States, privately
held corporations are not required to publish any financials.
On a direct call, nobody
accepted to answer our questions.
We sent a fax but no answer
received.
Outside sources (bank) gave
estimate sales for year 2014 in the range of
USD 7,000,000=
The business is said to be
profitable.
Banks: People’s United Bank
Legal filings
& complaints:
As of today date, there is no legal filing pending with the Courts.
Secured debts
summary (UCC):
None